SYSTEMIC LYMPHOBLASTOID INTERFERON THERAPY IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS .1. CLINICAL AND MRI EVALUATION

被引：72

作者：

KASTRUKOFF, LF

OGER, JJ

HASHIMOTO, SA

SACKS, SL

LI, DK

PALMER, MR

KOOPMANS, RA

PETKAU, AJ

BERKOWITZ, J

PATY, DW

机构：

[1] UNIV BRITISH COLUMBIA,DEPT MED,DIV INFECT DIS,VANCOUVER V6T 1W5,BC,CANADA

[2] UNIV BRITISH COLUMBIA,DEPT RADIOL,VANCOUVER V6T 1W5,BC,CANADA

[3] UNIV BRITISH COLUMBIA,DEPT STAT,STAT CONSULTING & RES LAB,VANCOUVER V6T 1W5,BC,CANADA

来源：

NEUROLOGY | 1990年 / 40卷 / 03期

关键词：

D O I：

10.1212/WNL.40.3_Part_1.479

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：479 / 486

页数：8

共 39 条

[1]

BASHAM TY, 1983, J IMMUNOL, V130, P1492

[2]

BENCZUR M, 1980, CLIN EXP IMMUNOL, V39, P657

[3]

CAMENGA DL, 1986, ARCH NEUROL-CHICAGO, V43, P1239

[4]

CROXTON FE, 1959, STATISTICS APPLICATI

[5]

Fleiss JL., 1981, STAT METHODS RATES P, V2

[6]

HABER A, 1985, MRD MINIMAL RECORD D

[7]

HARFAST B, 1981, J IMMUNOL, V127, P2146

[8] THE EFFECT OF RECOMBINANT ALPHA-2-INTERFERON ON DEFECTIVE NATURAL-KILLER CELL-ACTIVITY IN MULTIPLE-SCLEROSIS [J].

HIRSCH, RL ;

JOHNSON, KP .

NEUROLOGY, 1985, 35 (04) :597-600

[9]

HO M, 1982, PHARMACOL REV, V34, P119

[10]

HUDDLESTONE JR, 1979, J IMMUNOL, V123, P1615

← 1 2 3 4 →